SCHEMBL2929624

SCHEMBL2929624

CCc1ccccc1Nc1nc2ccc(C(=O)O)cc2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
RAB9A P51151 2/20 0.54
KDM4E B2RXH2 1/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
AKR1C3 P42330 1/20 0.52
HSP90AA1 P07900 1/20 0.51
ESR2 Q92731 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
POLB P06746 1/20 0.51
ABL1 P00519 5/20 0.49
ABCC4 O15439 1/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
KDR P35968 1/20 0.49
HTT P42858 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2930184 0.92 AKR1C3 (0.49) ALDH1A1RAB9AKDM4EGAAMAPT
SCHEMBL2926215 0.91 RAB9A (0.54) ALDH1A1RAB9AKDM4EGAAMAPT
SCHEMBL2932936 0.90 AKR1C3 (0.47) ALDH1A1RAB9AKDM4EGAAMAPT
SCHEMBL2930367 0.88 MAPT (0.52) ALDH1A1RAB9AKDM4EGAAMAPT
SCHEMBL2928155 0.87 AKR1C3 (0.53) ALDH1A1RAB9ASMN1; SMN2AKR1C3HSP90AA1
SCHEMBL2934474 0.83 AKR1C3 (0.54) ALDH1A1RAB9ASMN1; SMN2AKR1C3HSP90AA1
SCHEMBL2927124 0.82 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2AKR1C3HSP90AA1ESR2
SCHEMBL2931503 0.82 AKR1C3 (0.51) ALDH1A1MAPTSMN1; SMN2AKR1C3HSP90AA1
SCHEMBL2927341 0.82 LMNA (0.65) ALDH1A1RAB9AMAPTSMN1; SMN2AKR1C3
SCHEMBL2931480 0.82 AKR1C3 (0.51) ALDH1A1RAB9ASMN1; SMN2AKR1C3HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377983-B2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors TRANSTECH PHARMA, INC. (US) 2013-02-19 US disclosed
US-7820821-B2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors TRANSTECH PHARMA, INC. (US) 2010-10-26 US disclosed
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors TRANSTECH PHARMA, INC. (US) 2010-06-17 US disclosed
EP-1987028-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS AURORA KINASE INHIBITORS Transtech Pharma, Inc. (US) 2008-11-05 EP disclosed
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors VTVX HOLDINGS I LLC 2007-09-20 US disclosed
WO-2007095124-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS AURORA KINASE INHIBITORS TRANSTECH PHARMA, INC. (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors AURKC, AURKA, AURKB ALDH1A1 3036/4885RAB9A 3858/4885KDM4E 769/4885
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors AURKC, AURKA, AURKB ALDH1A1 3036/4885RAB9A 3858/4885KDM4E 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.